Literature DB >> 7341300

Serum supplements and serum-free media: applicability for microcarrier culture of animal cells.

J M Clark, C Gebb, M D Hirtenstein.   

Abstract

Several different combinations of serum supplements and also serum-free media were examined for their ability to support the growth of MRC-5 and Vero cells on Cytodex microcarriers. Greater economy of serum was achieved for routine microcarrier culture by selecting the type of serum supplement, on the basis of whether the supplement was to support attachment and growth of cells at low densities or growth of cells at later stages in the culture cycle. Further economy was achieved by altering the serum concentration according to the requirements of each stage of the culture cycle. More consistent results were obtained when batches of serum were selected on the basis of quality control tests with microcarrier culture as well as with monolayer culture. Low serum and serum-free media were able to support the growth of cells in microcarrier cultures. A mixture of DME/Medium 199 (50/50) containing foetal calf serum (0.5%, v/v), BSA and EGF supported growth of MRC-5 and Vero cells to nearly the same extent as DME/Medium 199 containing 10% (v/v) foetal calf serum. Serum-free media was used to achieve cell yields at least one half of those attained with serum-supplemented media. Maximum growth was obtained when DME/Medium 199 was supplemented with fibronectin, BSA, insulin, transferrin, putrescine, fetuin and EFG. Fetuin was omitted and replaced by dexamethasone and trace metals with only a slight reduction in cell yield. Fibronectin was essential in all serum-free media.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341300

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  6 in total

1.  Low-serum medium development for human diploid fibroblast microcarrier cultures.

Authors:  S P Forestell; N Kalogerakis; L A Behie
Journal:  Appl Microbiol Biotechnol       Date:  1992-11       Impact factor: 4.813

Review 2.  Strategies for optimising serum-free media.

Authors:  G Hewlett
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Authors:  Hiroto Miwa; Yoshiki Hashimoto; Keiji Tensho; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2011-10-15       Impact factor: 2.058

4.  Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

Authors:  R Jordan; J Pepe; P A Schaffer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  In vitro Proliferation of Human Bone Marrow Mesenchymal Stem Cells Employing Donor Serum and Basic Fibroblast Growth Factor.

Authors:  Mutsumi Takagi; Tetsuya Nakamura; Chikayoski Matsuda; Takako Hattori; Shigeyuki Wakitani; Toshiomi Yoshida
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

6.  Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium.

Authors:  Sébastien Quesney; Annie Marc; Catherine Gerdil; Cyrille Gimenez; Jacqueline Marvel; Yves Richard; Bernard Meignier
Journal:  Cytotechnology       Date:  2003-05       Impact factor: 2.058

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.